Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial

the Dutch Pancreatic Cancer Group

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences